Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes

Molecular and Biochemical Parasitology

Volumn 31, Issue 2, 1988, Pages 149-162

  Beach, David H ^a   Goad, L John ^b   Holz Jr , George G ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Fluconazole; Itraconazole; Ketoconazole; Leishmania; Promastigote; Sterol

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; DRUG THERAPY; LEISHMANIA; NONHUMAN; PROMASTIGOTE; PROTOZOON; STEROL SYNTHESIS;

ANIMAL; ANTIFUNGAL AGENTS; CHEMISTRY; CHOLESTEROL; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, THIN LAYER; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA MEXICANA; LEISHMANIA TROPICA; MASS FRAGMENTOGRAPHY; STEROLS; SUPPORT, U.S. GOV'T, P.H.S.; TRIAZOLES;

EID: 0023765496     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-6851(88)90166-1     Document Type: Article

References (54)

1. Experimental chemotherapy of leishmaniasis — a critical review
2. Protozoan infections of man: American trypanosomiasis and leishmaniasis
3. First International Symposium on Itraconazole A summary
4. Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice
5. Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro
6. Activity of imidazoles against Leishmania tropica in human macrophage cultures
7. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs
8. Activity of anti-leishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages
9. Estudio ultrastructural de la actividad de varios farmacos frente a Leishmania mexicana en infeccion experimental en el hamster dorado (Mesocricetus auratus)
10. Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo
11. Cutaneous leishmaniasis from Belize-treatment with ketoconazole
12. Ketoconazole in cutaneous leishmaniasis: results of a pilot study
13. Response to ketoconazole in two cases of long-standing cutaneous leishmaniasis
14. La leishmaniose cutanée du Nord de L'Algérie
15. Ketoconazole in cutaneous leishmaniasis
16. Oral ketoconazole in the treatment of leishmaniasis
17. In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents
18. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis
19. Molecular basis for the antifungal activity of the azole derivatives ketoconazole and itraconazole
20. 14DM purified from Saccharomyces cerevisiae microsomes
21. The activity of fluconazole (UK-49,858), a novel bis-triazole antifungal and ketoconazole against fungal and mammalian sterol C14 demethylases
22. Sterols of Leishmania species
23. Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes
24. Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells
25. Effects of ketoconazole on growth and sterol biosynthesis of Leishmania promastigotes in culture
26. Cultivation of Leishmania donovani and Leishmania braziliensis in defined medium
27. Effect of the allylamine antifungal drug SF 86–327 on the growth and sterol synthesis of Leishmania mexicana mexicana promastigotes
28. Quantitative analysis of cholesterol in 5 to 20 μl of plasma
29. Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes
30. Broth dilution testing of Candida albicans susceptibility to ketoconazole
31. The in vitro evaluation of azoles
32. Biochemical targets for antifungal azole derivatives: Hypothesis on the mode of action
33. Mechanism of fungal growth suppression by inhibitors of ergosterol biosynthesis
34. Cholesterol biosynthesis and metabolism
35. Modulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by azole antimycotics requires lanosterol demethylation, but not 24,25-epoxylanosterol formation
36. In situ accumulation of 3β-hydroxylanost-8-en-32-aldehyde in hepatocyte cultures
37. A relationship between the activities of hepatic lanosterol 14α-demethylase and 3-hydroxy-3-methylglutaryl-CoA reductase
38. Trypanosoma brucei brucei obtains cholesterol from plasma lipoproteins
39. Receptor-mediated endocytosis in the bloodstream form of Trypanosoma brucei
40. Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein
41. Structure-function relationships for sterols in Saccharomyces cerevisiae
42. Sterol synergism in yeast
43. v-src possibly involved in yeast cell cycle control: Positive in vivo regulation by sterol
44. Multiple functions for sterols in Saccharomyces cerevisiae
45. Physiological requirements for biosynthesis of multiple 24β-methyl sterols in Gibberella fujikuroi
46. Paclobutrazol inhibition of sterol biosynthesis in a cell suspension culture and evidence of an essential role for 24-ethylsterol in plant cell division
47. The sterol requirement of Tetrahymena setosa HZ-1
48. Growth and metabolism of phytosterols in Paramecium tetraurelia
49. Requirements for a second sterol biosynthetic mutation for viability of a sterol C-14 demethylation defect in Saccharomyces cerevisiae
50. Sterol structure and membrane function
51. Lanosterol and cholesterol have different effects on phospholipid acyl chain ordering
52. Characterization of a cytochrome P450 deficient mutant of Candida albicans
53. Azole antifungal agents: Emphasis on new triazoles